A LinkedIn post from Forge Biologics highlights the company’s emphasis on resilient infrastructure supporting its gene therapy manufacturing operations. The post notes that its flywheel uninterruptible power supply system is described as capable of generating enough power to supply 32,000 homes for an hour, underscoring the scale of its backup capabilities.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, this power resiliency is positioned as critical to maintaining reliable manufacturing for clients and patients, helping ensure continuity in the production of gene therapies. The content, which promotes a video discussion with an internal leader about building “the Hearth” facility with resilience at its core, suggests continued investment in operational reliability that may support Forge Biologics’ capacity utilization, service quality, and long-term competitiveness in contract gene therapy manufacturing.